Your browser doesn't support javascript.
loading
Application of Organoids in Lung Cancer Precision Medicine / 中国肺癌杂志
Chinese Journal of Lung Cancer ; (12): 615-620, 2020.
Article Dans Chinois | WPRIM | ID: wpr-826933
ABSTRACT
Precision medicine is an approach to rational treatment selection in the overall management of lung cancer nowadays. The introduction of the patient-derived organoid (PDO) model has established the "black-box" decision-making system from the perspective of in-vitro functional models. This may assist as a complement to the treatment selection strategy based on gene-drug correlation. Further validation must be done in multi-dimensional characteristics recapitulation of the primary tumor in organoids and in large-scale randomized controlled clinical trials. This article will give an introduction to the organoid model and review the application scenarios of organoids in the context of the precise treatment of existing lung cancer.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Essai clinique contrôlé / Étude pronostique langue: Chinois Texte intégral: Chinese Journal of Lung Cancer Année: 2020 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Type d'étude: Essai clinique contrôlé / Étude pronostique langue: Chinois Texte intégral: Chinese Journal of Lung Cancer Année: 2020 Type: Article